Evidence map›Paper›PMID 33532492›Full record

ArticleBioMed research international2021

A Matrix Metalloproteinase-2-Based Nomogram to Assess the Risk of Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients.

Che-Yi Chou, Chin-Chung Tseng, Jin-Bor Chen, Chin-Chuan Hung, Chiu-Ching Huang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Che-Yi ChouCollege of Medicine, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0003-4029-9097
Chin-Chung TsengDivision of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Jin-Bor ChenDivision of Nephrology, Kaohsiung Chang Gung Memorial Hospital of The C.G.M.F, Kaohsiung, Taiwan.
Chin-Chuan HungSchool of Pharmacy, China Medical University, Taichung, Taiwan.
Chiu-Ching HuangCollege of Medicine, China Medical University, Taichung, Taiwan.ORCID https://orcid.org/0000-0003-3545-9770
China Medical University · TWInternational Baccalaureate · CHKaohsiung Chang Gung Memorial Hospital · TWNational Cheng Kung University Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEncapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD). So far, there is no biomarker-based prediction tool available for EPS. Matrix metalloproteinase-2 (MMP-2) is a protein involved in the breakdown of the extracellular matrix, and the effluent MMP-2 can be a potential biomarker of EPS. This study is aimed at developing a nomogram for EPS based on effluent MMP-2 levels.

resultsThe effluent MMP-2 levels in EPS patients were significantly higher than those in normal PD patients (

conclusionA nomogram based on effluent MMP-2 levels and PD duration may predict EPS with high accuracy.

Indexed as

Peritoneal FibrosisAgedArea Under CurveBiomarkersCase-Control StudiesFemaleHumansMaleMatrix Metalloproteinase 2Middle AgedNomogramsPeritoneal DialysisBiomarkersMatrix Metalloproteinase 2MMP2 protein, human

Identifiers

PMID33532492
PMCPMC7837760
OpenAlexW3125369089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.